Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Isal Amlat Investments Ltd is an Israel-based investment holding company that manages a diverse portfolio of assets across multiple sectors, including industry, real estate, and life sciences. The company operates as a financial vehicle for strategic acquisitions and corporate development, providing capital and oversight to its various subsidiary holdings. Historically, Isal Amlat has been a notable player in the Israeli capital market through its significant investments in specialized entities such as Bio-Light Israeli Life Sciences Investments and the medical device firm Medispec. While the firm is a diversified holding entity rather than a direct drug developer, its historical focus on healthcare and life science ventures has made it a relevant participant in the Israeli biotech ecosystem. The company is publicly traded on the Tel Aviv Stock Exchange under the ticker symbol ISAL.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Isal Amlat Investments.